SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-16-012129
Filing Date
2016-11-10
Accepted
2016-11-10 07:05:18
Documents
12
Period of Report
2016-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5757
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 343931
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 267352
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 7314
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 7302
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 8239
7 GRAPHIC exhibi1.jpg GRAPHIC 9916
8 GRAPHIC trillogo.jpg GRAPHIC 6558
9 GRAPHIC exhibit99-2x5x1.jpg GRAPHIC 28867
10 GRAPHIC exhibit99-2x7x1.jpg GRAPHIC 20521
11 GRAPHIC exhibit99-2x8x1.jpg GRAPHIC 21863
12 GRAPHIC exhibit99-2x9x1.jpg GRAPHIC 10029
  Complete submission text file 0001062993-16-012129.txt   776360
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 161985958
SIC: 2834 Pharmaceutical Preparations